Attention Lanham/Largo Patients: Our new Largo office is now open and our Lanham location is closed permanently. Largo’s address is 9333 Healthcare Way Suite 4100 Largo, MD 20774.

HIPAA Alert:
Potential Data Breach : Learn More

Trial Protocol ID USOR 22123_1403-0011_Brightline-2 *STAR*

Trial Description

A Phase IIa/IIb, open-label, single-arm, multi-centre trial of brigimadlin (BI 907828) for treatment of patients with locally advanced/ metastatic, MDM2 amplified, TP53 wild-type biliary tract adenocarcinoma, pancreatic ductal adenocarcinoma, or other selected solid tumours

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Sponsor

  • BOEHRINGER INGELHEIM

ClinicalTrials.gov NCT ID

  • NCT05512377